Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Devalina Law

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Journal of Pharmaceutical Sciences|October 15, 2022
Design of a Re-Dispersible High Drug Load Amorphous FormulationHardeep S Oberoi, Freddy Arce, Hitesh S Purohit, et al.
Journal of Pharmaceutical Sciences|September 2, 2003
Crystallization kinetics of amorphous nifedipine studied by model-fitting and model-free approachesDeliang Zhou, Eric A Schmitt, Geoff G Zhang, et al.
Journal of Pharmaceutical Sciences|June 24, 2003
Model-free treatment of the dehydration kinetics of nedocromil sodium trihydrateDeliang Zhou, Eric A Schmitt, Geoff G Z Zhang, et al.
Journal of Pharmaceutical Sciences|February 6, 2004
Ritonavir-PEG 8000 amorphous solid dispersions: in vitro and in vivo evaluationsDevalina Law, Eric A Schmitt, Kennan C Marsh, et al.
Lab on a Chip|May 20, 2025
Human mesofluidic intestinal model for studying transport of drug carriers and bacteria through a live mucosal barrierChia-Ming Wang, Hardeep S Oberoi, Devalina Law, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2024
Human Mesofluidic Intestinal Model for Studying Transport of Drug Carriers and Bacteria Through a Live Mucosal BarrierChia-Ming Wang, Hardeep S Oberoi, Devalina Law, et al.
Journal of Pharmaceutical Sciences|October 20, 2024
Scale-up and clinical bioavailability assessment of a 45% drug loaded amorphous nanoparticle formulation of a BCS IV compound for oral deliveryMengqi Yu, Deliang Zhou, Hardeep S Oberoi, et al.
Journal of Pharmaceutical Sciences|March 22, 2014
Understanding and managing the impact of HPMC variability on drug release from controlled release formulationsDeliang Zhou, Devalina Law, Judie Reynolds, et al.
Journal of Pharmaceutical Sciences|October 13, 2023
Proof-of-Concept in Developing a 45% Drug Loaded Amorphous Nanoparticle FormulationHitesh S Purohit, Deliang Zhou, Mengqi Yu, et al.
CNS Neuroscience & Therapeutics|May 17, 2008
Preclinical characterization of A-582941: a novel alpha7 neuronal nicotinic receptor agonist with broad spectrum cognition-enhancing propertiesKarin R Tietje, David J Anderson, R Scott Bitner, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Journal of Pharmaceutical Sciences|October 15, 2022
Design of a Re-Dispersible High Drug Load Amorphous FormulationHardeep S Oberoi, Freddy Arce, Hitesh S Purohit, et al.
Journal of Pharmaceutical Sciences|September 2, 2003
Crystallization kinetics of amorphous nifedipine studied by model-fitting and model-free approachesDeliang Zhou, Eric A Schmitt, Geoff G Zhang, et al.
Journal of Pharmaceutical Sciences|June 24, 2003
Model-free treatment of the dehydration kinetics of nedocromil sodium trihydrateDeliang Zhou, Eric A Schmitt, Geoff G Z Zhang, et al.
Journal of Pharmaceutical Sciences|February 6, 2004
Ritonavir-PEG 8000 amorphous solid dispersions: in vitro and in vivo evaluationsDevalina Law, Eric A Schmitt, Kennan C Marsh, et al.
Lab on a Chip|May 20, 2025
Human mesofluidic intestinal model for studying transport of drug carriers and bacteria through a live mucosal barrierChia-Ming Wang, Hardeep S Oberoi, Devalina Law, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2024
Human Mesofluidic Intestinal Model for Studying Transport of Drug Carriers and Bacteria Through a Live Mucosal BarrierChia-Ming Wang, Hardeep S Oberoi, Devalina Law, et al.
Journal of Pharmaceutical Sciences|October 20, 2024
Scale-up and clinical bioavailability assessment of a 45% drug loaded amorphous nanoparticle formulation of a BCS IV compound for oral deliveryMengqi Yu, Deliang Zhou, Hardeep S Oberoi, et al.
Journal of Pharmaceutical Sciences|March 22, 2014
Understanding and managing the impact of HPMC variability on drug release from controlled release formulationsDeliang Zhou, Devalina Law, Judie Reynolds, et al.
Journal of Pharmaceutical Sciences|October 13, 2023
Proof-of-Concept in Developing a 45% Drug Loaded Amorphous Nanoparticle FormulationHitesh S Purohit, Deliang Zhou, Mengqi Yu, et al.
CNS Neuroscience & Therapeutics|May 17, 2008
Preclinical characterization of A-582941: a novel alpha7 neuronal nicotinic receptor agonist with broad spectrum cognition-enhancing propertiesKarin R Tietje, David J Anderson, R Scott Bitner, et al.
Pageof 2